Michael Greenwood

Feature Writer

B.Sc. Chemistry, M.Sc. Drug Design and Discovery

Michael graduated from the University of Salford with a PhD in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.

Articles from Michael

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

A national statistics study on vaccine uptake disparity in England

The disparity in vaccination rates across England is investigated based on demographic variables, finding significant differences based on ethnicity and religion.

11 Oct 2021

Analysis of SARS-CoV-2 Delta variant transmissibility across New England, USA

A recent study compares the transmissibility of the SARS-CoV-2 Alpha and Delta variants in six states across New England in the United States

11 Oct 2021

A simple method to predict future COVID-19 hospitalization

A simple model with the ability to forecast probable COVID-19 hospitalization numbers in the short term is described, requiring less input information and generating more accurate predictions than other models.

11 Oct 2021

The role of inhibiting palmitoylation of the SARS-CoV-2 spike protein on viral infectivity

It is demonstrated that palmitoylation of the first five cysteine residues of the C-terminal domain of the SARS-CoV-2 spike protein facilitates cell entry and the formation of syncytia.

11 Oct 2021